Breaking from the paradigm of antibody-drug conjugates: Evaluation of clinical pharmacokinetics and safety of bicycle toxin conjugates (BTCs)

被引：0
|
作者：
Bader, Justin
McKean, Meredith
DeMars, Leslie Robbins
Lu, Yasong
Li, Mengyao
Dickson, Amy
Bennett, Gavin
Arroyo, Santiago
Fontana, Elisa
Carter, Louise
Ahnert, Jordi Rodon
Falchook, Gerald Steven
Xu, Hongmei
机构：
[1] Bicycle Therapeut, Cambridge, MA USA
[2] Sarah Cannon Res Inst, Nashville, TN USA
[3] BicycleTx Ltd, Cambridge, England
[4] Sarah Cannon Res Inst UK, London, England
[5] Univ Manchester, Manchester, England
[6] Christie NHS Fdn Trust, Manchester, England
[7] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[8] HealthONE, Sarah Cannon Res Inst, Denver, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3088
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Considerations for the Nonclinical Safety Evaluation of Antibody-Drug Conjugates
    Fisher, J. Edward, Jr.
    ANTIBODIES, 2021, 10 (02)
  • [2] Clinical Pharmacology of Antibody-Drug Conjugates
    Mahmood, Iftekhar
    ANTIBODIES, 2021, 10 (02)
  • [3] Safety and Tolerability of Antibody-Drug Conjugates in Cancer
    Wolska-Washer, Anna
    Robak, Tadeusz
    DRUG SAFETY, 2019, 42 (02) : 295 - 314
  • [4] Safety and Tolerability of Antibody-Drug Conjugates in Cancer
    Anna Wolska-Washer
    Tadeusz Robak
    Drug Safety, 2019, 42 : 295 - 314
  • [5] Pharmacokinetics and toxicity considerations for antibody-drug conjugates: an overview
    Hejmady, Siddhanth
    Pradhan, Rajesh
    Kumari, Shobha
    Pandey, Meghna
    Dubey, Sunil K.
    Taliyan, Rajeev
    BIOANALYSIS, 2023, 15 (19) : 1193 - 1202
  • [6] Systematic review of recent advancements in antibody-drug and bicycle toxin conjugates for the treatment of urothelial cancer
    Domb, Chaim
    Garcia, Jorge A.
    Barata, Pedro C.
    Mendiratta, Prateek
    Rao, Santosh
    Brown, Jason R.
    THERAPEUTIC ADVANCES IN UROLOGY, 2024, 16
  • [7] Toxicities From Antibody-Drug Conjugates
    Johns, Andrew C.
    Campbell, Matthew T.
    CANCER JOURNAL, 2022, 28 (06): : 469 - 478
  • [8] Prediction of Human Pharmacokinetics of Antibody-Drug Conjugates From Nonclinical Data
    Li, Chunze
    Zhang, Cindy
    Deng, Rong
    Leipold, Douglas
    Li, Dongwei
    Latifi, Brandon
    Gao, Yuying
    Zhang, Crystal
    Li, Zao
    Miles, Dale
    Chen, Shang-Chiung
    Samineni, Divya
    Wang, Bei
    Agarwal, Priya
    Lu, Dan
    Prabhu, Saileta
    Girish, Sandhya
    Kamath, Amrita V.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (05): : 534 - 544
  • [9] Synthesis and Evaluation of Camptothecin Antibody-Drug Conjugates
    Li, Wei
    Veale, Karen H.
    Qiu, Qifeng
    Sinkevicius, Kerstin W.
    Maloney, Erin K.
    Costoplus, Juliet A.
    Lau, Janet
    Evans, Helen L.
    Setiady, Yulius
    Ab, Olga
    Abbott, Stephen M.
    Lee, Jenny
    Wisitpitthaya, Somsinee
    Skaletskaya, Anna
    Wang, Lintao
    Keating, Thomas A.
    Chari, Ravi V. J.
    Widdison, Wayne C.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (10): : 1386 - 1392
  • [10] The clinical development of antibody-drug conjugates - lessons from leukaemia
    Jabbour, Elias
    Paul, Shilpa
    Kantarjian, Hagop
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (07) : 418 - 433
12345